Man S - Search Results

1

Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6.

Evans M, Borysiewicz LK, Evans AS, Rowe M, Jones M, Gileadi U, Cerundolo V, Man S. Evans M, et al. Among authors: man s. J Immunol. 2001 Nov 1;167(9):5420-8. doi: 10.4049/jimmunol.167.9.5420. J Immunol. 2001. PMID: 11673561

2

Competition between CTL narrows the immune response induced by prime-boost vaccination protocols.

Palmowski MJ, Choi EM, Hermans IF, Gilbert SC, Chen JL, Gileadi U, Salio M, Van Pel A, Man S, Bonin E, Liljestrom P, Dunbar PR, Cerundolo V. Palmowski MJ, et al. Among authors: man s. J Immunol. 2002 May 1;168(9):4391-8. doi: 10.4049/jimmunol.168.9.4391. J Immunol. 2002. PMID: 11970981

3

HPV16 E6 29-38-specific T cells kill cervical carcinoma cells despite partial evasion of T-cell effector function.

Thomas KJ, Smith KL, Youde SJ, Evans M, Fiander AN, Borysiewicz LK, Man S. Thomas KJ, et al. Among authors: man s. Int J Cancer. 2008 Jun 15;122(12):2791-9. doi: 10.1002/ijc.23475. Int J Cancer. 2008. PMID: 18366058

4

Influenza A antigen exposure selects dominant Vbeta17+ TCR in human CD8+ cytotoxic T cell responses.

Lawson TM, Man S, Williams S, Boon AC, Zambon M, Borysiewicz LK. Lawson TM, et al. Among authors: man s. Int Immunol. 2001 Nov;13(11):1373-81. doi: 10.1093/intimm/13.11.1373. Int Immunol. 2001. PMID: 11675369

5

Functional differences between influenza A-specific cytotoxic T lymphocyte clones expressing dominant and subdominant TCR.

Lawson TM, Man S, Wang EC, Williams S, Amos N, Gillespie GM, Moss PA, Borysiewicz LK. Lawson TM, et al. Among authors: man s. Int Immunol. 2001 Nov;13(11):1383-90. doi: 10.1093/intimm/13.11.1383. Int Immunol. 2001. PMID: 11675370

6

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

Borysiewicz LK, Fiander A, Nimako M, Man S, Wilkinson GW, Westmoreland D, Evans AS, Adams M, Stacey SN, Boursnell ME, Rutherford E, Hickling JK, Inglis SC. Borysiewicz LK, et al. Among authors: man s. Lancet. 1996 Jun 1;347(9014):1523-7. doi: 10.1016/s0140-6736(96)90674-1. Lancet. 1996. PMID: 8684105 Clinical Trial.

7

Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes.

Evans EM, Man S, Evans AS, Borysiewicz LK. Evans EM, et al. Among authors: man s. Cancer Res. 1997 Jul 15;57(14):2943-50. Cancer Res. 1997. PMID: 9230206

8

Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III.

Nimako M, Fiander AN, Wilkinson GW, Borysiewicz LK, Man S. Nimako M, et al. Among authors: man s. Cancer Res. 1997 Nov 1;57(21):4855-61. Cancer Res. 1997. PMID: 9354449

9

Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens.

Youde SJ, Dunbar PR, Evans EM, Fiander AN, Borysiewicz LK, Cerundolo V, Man S. Youde SJ, et al. Among authors: man s. Cancer Res. 2000 Jan 15;60(2):365-71. Cancer Res. 2000. PMID: 10667589

10

Clinical studies of human papilloma vaccines in cervical cancer.

Adams M, Borysiewicz L, Fiander A, Man S, Jasani B, Navabi H, Evans AS, Mason M. Adams M, et al. Among authors: man s. Adv Exp Med Biol. 2001;495:419-27. doi: 10.1007/978-1-4615-0685-0_61. Adv Exp Med Biol. 2001. PMID: 11774604 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,166 results

Search Page

Filters